Optimizing Psoriasis Management with TYK2 Inhibitors - Episode 1
Addressing Challenges in Psoriasis with Evolving Treatment Landscape
Explore how TYK2 inhibitors reshape psoriasis care, as experts weigh comorbidities, infection screening, and treat-to-target goals to overcome real-world treatment hurdles.
Welcome back to another HCPLive Peers & Perspectives series. In this episode titled, ‘Addressing Challenges in Psoriasis with Evolving Treatment Landscape,’ Dr. Tina Bhutani-Jacques joins Dr. Mark Lebwohl to discuss the current state of psoriasis care. The conversation centers on the emergence of TYK2 inhibitors as a distinct class of treatment and how these agents provide new opportunities for patient management.
Dr. Lebwohl reflects on the dramatic evolution of psoriasis therapy, noting that while practitioners now have approximately 15 highly effective options, the abundance of choices presents its own challenges. He emphasizes that selecting the right treatment is a scientific process rather than an art form. The decision depends heavily on individual patient factors including the extent of the disease and a wide array of comorbidities. Dr. Lebwohl highlights that common conditions such as obesity, joint pain, cardiovascular risk, diabetes, and inflammatory bowel disease significantly influence which medication is most appropriate for a specific person. He also notes the importance of screening for infections like HIV or tuberculosis before finalizing a treatment plan. The experts conclude that the complexity of the psoriasis patient population requires a nuanced approach to positioning newer oral agents like TYK2 inhibitors. This episode sets the stage for a deeper dive into the latest efficacy and safety data that help clinicians navigate these real world treatment hurdles.
In the next episode, ‘Defining Treatment Goals and Addressing Unmet Needs in Psoriasis’, panelists will continue their discussion on psoriasis and highlight the importance of the treat to target approach while identifying remaining gaps in care for difficult to treat areas like the palms and soles. The experts emphasize that achieving clear skin is not just about aesthetics but about reducing systemic inflammation and long term cardiovascular risks.
